Background
Identification of new drug targets may extend treatment options for neuroendocrine tumors (NET) regardless of histologic classification or primary organ site.
Publications
Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets
– Caris Life Sciences
Download Publication